Potential new therapeutic for Relapsing MS patients

Zeposia is an oral sphingosine 1-phosphate receptor modulator indicated for the treatment of relapsing MS.
Post Reply
User avatar
MSUK
Family Elder
Posts: 2903
Joined: Wed Oct 14, 2009 2:00 pm
Contact:
Contact MSUK

Potential new therapeutic for Relapsing MS patients

Post by MSUK »

RADIANCE phase 2 trial of ozanimod, an investigational selective S1P 1 and 5 receptor modulators for relapsing multiple sclerosis (MS) patients results showed significant reductions in the cumulative number of total gadolinium-enhancing (GdE) lesions...Read more - http://www.ms-uk.org/MSnews
MS-UK - http://www.ms-uk.org/
Top
Post Reply

Return to “Zeposia (Ozanimod)”